Ambulatory Blood Pressure Monitoring

William White

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

Trouble with the LAD during Anterior STEMI

The Online Cardiac Catheterization Casebook

M. Kern

Lp(a): When to Measure it and What to Do About it

Collaborative CME and Research Network

M. O'Donoghue

Should Colchicine Become Standard Therapy for CAD?

Collaborative CME and Research Network

P. Ridker

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Scripps Health

M. Budoff

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Recent Cholesterol Guidelines and Integration into Clinical Practice

Vasculearn Network

J. Plutzky, L. Braun, J. Ross

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn